Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection
Name:
Katsanis_Hyperammonemia_with_f ...
Size:
111.5Kb
Format:
PDF
Description:
Final Accepted Manuscript
Affiliation
Univ Arizona, Dept PediatUniv Arizona, Ctr Canc
Issue Date
2018-04
Metadata
Show full item recordPublisher
WILEYCitation
Graetz R, Meyer R, Shehab K, Katsanis E. Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection. Transpl Infect Dis. 2018;20:e12839. https://doi.org/10.1111/tid.12839Journal
TRANSPLANT INFECTIOUS DISEASERights
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Hyperammonemia following hematopoietic cell transplantation (HCT) has been characterized as idiopathic and is associated with a very high mortality. A causal relationship between Ureaplasma infection and hyperammonemia in immunocompromised lung transplant recipients has recently been described. We document the first case of hyperammonemia following HCT associated with Ureaplasma parvum. The initiation of appropriate antibiotics resulted in rapid resolution of hyperammonemic encephalopathy and eradication of the implicating organism.Note
12 month embargo; published online: 23 January 2018ISSN
1398-22731399-3062
PubMed ID
29359847Version
Final accepted manuscriptAdditional Links
https://onlinelibrary.wiley.com/doi/abs/10.1111/tid.12839ae974a485f413a2113503eed53cd6c53
10.1111/tid.12839